International Symposium & CME on Modern Trends in Malaria
Department of Biotechnology, All India Institute of Medical Sciences

13^th February 2003 – Continuing Medical Education for Physicians and Biomedical Scientists Session 1: Modern Tools for Malaria 1pm to 5pm

Scope of CME

• Prof. M.G. Deo, Vice-President, Moving Academy of Medicine/ Biomedicine, Pune.

Changing Clinical Profile of Malaria

• B.S. Das, Ispat Hospital Rourkela.

Molecular Biology as a tool for Physicians

• Prof. Y.D. Sharma, AIIMS, Delhi.

Current trends in the diagnosis of malaria

§ Prof. J.C.Samantaray, AIIMS, Delhi.

Public Health Measures to control malaria

§ Dr. S.Patnaik, Former Director, NMEP.

Membranes as future therapeutic targets

§ C.A Pasternak, OIBC/ St George Medical School, London

Current Malaria Vaccines

§ A.S. Hill, Wellcome Labs, JR Hospital, Oxford.

Scope of CME

§ Prof. M.G. Deo, Vice-President, Moving Academy of Medicine/ Biomedicine, Pune.

Changing Clinical Profile of Malaria

§ B.S. Das, Ispat Hospital Rourkela.

Molecular Biology as a tool for Physicians

§ Prof. Y.D. Sharma, AIIMS, Delhi.

Current trends in the diagnosis of malaria

§ Prof. J.C.Samantaray, AIIMS, Delhi.

Public Health Measures to control malaria

§ Dr. S.Patnaik, Former Director, NMEP.

Membranes as future therapeutic targets

§ C.A Pasternak, OIBC/ St George Medical School, London

Current Malaria Vaccines

§ A.S. Hill, Wellcome Labs, JR Hospital, Oxford.

14^th February 2003 – International Symposium Session 2: Plenary Session: 9:30am to 1pm

Scope of the Symposium

§ I Nath, AIIMS, Delhi.

Oxford International Biomedical Centre

§ C.A. Pasternak, OIBC, UK.

'Roll Back Malaria'

§ V.P.Sharma, Former ADG, ICMR, Delhi.

Implications for Developing Countries

§ N.K. Ganguly, DG, ICMR, Delhi

Mosquito Control

§ C.F. Curtis, LSHTM, London

Session 3: Membranes / organells as targets: 2pm to 5pm

Studies on falciparum malaria by atomic force and surface potential microscopy: a new therapeutic target

§ M.Aikawa, TU, Japan

Erythrocyte Membrane as a Target

§ Kiaran Kirk, ANU, Canberra, Australia

Receptor-ligand interactions mediating erythrocyteinvasion and cytoadherence by malaria parasites

§ Chetan Chitnis, ICGEB, Delhi

Parasite Membrane as a Target

§ S.Krishna, SGHMS, London

Parasite mitochondria as a target of chemotherapy

§ Kiyoshi Kita, TU, Japan

An alternative view of bioenergetics in malaria parasites

§ Akhil B Vaidya, DUCM, PA, USA

15^th February 2003 – Session 4: Novel Metabolic Pathways as targets: 9:£0am to 1pm

Malarial metalloprotease

§ Y.D. Sharma, AIIMS, Delhi

Plasmodium serine proteases implicated in red cell invasion; molecular characterization and validation as drug targets

§ C.Braun-Breton, Pasteur Inst., France

The Fab end of Plasmodium FAS and more

§ N. Surolia, JNC, Bangalore

New Features of Parasite Biology

§ G.Padmanabhan, IISc, Bangalore

Plant based therapeutics - Artemisin

§ V.S Chauhan, ICGEB, Delhi

Session 5: Immunology / Genetics / Vaccines: 2pm to 5pm

Epidemiology as a modern tool

§ Sunetra Gupta, Oxford

Novel Protective immunogens of P. falciparum

§ S. Sharma, TIFR, Mumbai

Cytokines in natural infection

§ P. Deshpande, NCCS, Pune

Malaria Vaccine - the' Oxford Approach'

§ A.S. Hill, Welcome Labs/JR Hospital, Oxford

Update on International Congress of Malaria

§ S. Krishna, SGHMS, London

Diversity in Plasmodium parasites; knowing and incorporating this information in intervention efforts

§ Altaf Lal, CDC, USA

Transmission blocking Immunity

§ Nirbhay Kumar, JHU, USA

Genetic and molecular approaches to malaria vector and parasite population studies

§ S. Subbarao, MRC, Delhi

Sponsored By:

Moving Academy of Medicine/ Biomedicine, India and Oxford International Biomedical Centre, U.K.